CMS certification 210044
Greater Baltimore Medical Center
6701 North Charles Street, Baltimore, MD 21204
Greater Baltimore Medical Center has a CMS overall rating of 5 out of 5 stars. 77% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 24 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 6 and worse on 1. Emergency patients spend a median of 3 h 48 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 775 completed surveys, 23% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | MD | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 46,532 visits sampled · US median for EDs of the same volume: 3 h 22 min | 3 h 48 min | 4 h 6 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 2,987 visits sampled | 7 h 37 min | 6 h 55 min | 4 h 17 min |
| Left before being seen Lower is better · 59,033 patients | 4% | 3% | 2% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 447 patients | 47% | 65% | 65% |
How Greater Baltimore Medical Center compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Greater Baltimore Medical CenterThis hospital | 5/5 | 77% | 3 h 48 min | 6 better 1 worse |
| Mercy Medical Center INCSame city | 3/5 | 80% | 3 h 57 min | 2 better 2 worse |
| University of Maryland Medical CenterSame city | 3/5 | 70% | 5 h 9 min | 2 better 2 worse |
| University of MD Medical Center Midtown CampusSame city | 3/5 | 66% | 4 h 3 min | 1 better 1 worse |
| VA Maryland Healthcare System - BaltimoreSame city | 2/5 | 56% | — | 1 better 3 worse |
| Sinai Hospital of BaltimoreSame city | 3/5 | 61% | 4 h 17 min | 4 better 6 worse |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Baltimore.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 2,870 cases | Too few cases | 2.9% | 3.9% |
| Heart attack 31 cases | Too few cases | 12.5% | 11.9% |
| Heart failure 505 cases | Too few cases | 10.7% | 11.1% |
| Pneumonia 618 cases | Too few cases | 13.6% | 15.2% |
| Stroke 177 cases | Too few cases | 10.4% | 11.9% |
| COPD 252 cases | Too few cases | 6.4% | 8.6% |
1 more measure had too few cases here to report.
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | Worse | 1.6 likely 1.3 – 1.9 | 1 |
| After hip or knee replacement 71 cases | Too few cases | 4.3% | 4.1% |
| Deaths after a serious but treatable surgical complication 71 cases | No different | 175.71 per 1,000 likely 121.36 per 1,000 – 230.05 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 6,233 cases | Worse | 2.33 per 1,000 likely 1.69 per 1,000 – 2.97 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 8,399 cases | No different | 0.26 per 1,000 likely 0.06 per 1,000 – 0.47 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 8,541 cases | No different | 0.3 per 1,000 likely 0.11 per 1,000 – 0.49 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 1,471 cases | No different | 2.93 per 1,000 likely 1.51 per 1,000 – 4.36 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 758 cases | No different | 1.28 per 1,000 likely 0 per 1,000 – 2.79 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 692 cases | No different | 12.35 per 1,000 likely 5.94 per 1,000 – 18.75 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 1,565 cases | No different | 2.47 per 1,000 likely 0.52 per 1,000 – 4.43 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 715 cases | No different | 7.18 per 1,000 likely 3.85 per 1,000 – 10.52 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 446 cases | No different | 2.2 per 1,000 likely 0.75 per 1,000 – 3.65 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 1,685 cases | No different | 1.1 per 1,000 likely 0.21 per 1,000 – 1.99 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | No different | 0.63 likely 0.11 – 2.07 | 1 |
| Urinary tract infections from catheters (CAUTI) | No different | 0.26 likely 0.01 – 1.3 | 1 |
| Surgical site infections after colon surgery | No different | 1.91 likely 0.93 – 3.51 | 1 |
| Surgical site infections after abdominal hysterectomy | No different | 0.92 likely 0.05 – 4.53 | 1 |
| MRSA bloodstream infections | No different | 0.23 likely 0.01 – 1.14 | 1 |
| C. diff intestinal infections | Better | 0.41 likely 0.23 – 0.68 | 1 |
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after heart failure 587 cases | Too few cases | 21.1% | 21.3% |
| Readmitted after pneumonia 647 cases | Too few cases | 15.3% | 17.3% |
| Readmitted after COPD 272 cases | Too few cases | 19.4% | 20% |
| Readmitted after hip or knee replacement 70 cases | Too few cases | 5.7% | 5.8% |
| Days back in hospital after heart failure 599 cases | Too few cases | 7.1 days per 100 | — |
| Days back in hospital after pneumonia 668 cases | Too few cases | -13.3 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 2,672 cases | No different | 10.3 per 1,000 likely 8 per 1,000 – 13.1 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 52 cases | No different | 9.8 per 100 likely 6.9 per 100 – 13.7 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 52 cases | No different | 5 per 100 likely 3.2 per 100 – 7.7 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 1,005 cases | No different | 0.8 likely 0.7 – 1.1 | — |
4 more measures had too few cases here to report.
Clinicians registered at this address
362 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Anesthesiology | 57 |
| Internal Medicine | 47 |
| Physician Assistant | 35 |
| Nurse Anesthetist, Certified Registered | 31 |
| Emergency Medicine | 20 |
| Adult Health | 16 |
| Hospitalist | 14 |
| Registered Nurse | 12 |
| Family | 9 |
| Acute Care | 8 |
| Anatomic Pathology & Clinical Pathology | 8 |
| Geriatric Medicine | 8 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $1.2M
- 2020 $282,247
- 2021 $450,650
- 2022 $215,978
- 2023 $225,200
- 2024 $242,025
- 2025 $360,161
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Medical devices and supplies on long-term loan | $11,181 | 8 |
| Debt forgiveness | $4,052 | 2 |
| Space rental and facility fees | $2,500 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Daiichi Sankyo Inc. | $80,000 | 2 |
| AstraZeneca UK Limited | $71,872 | 3 |
| AstraZeneca Pharmaceuticals LP | $51,772 | 3 |
| PharmaEssentia USA Corporation | $36,918 | 6 |
| Celgene Corporation | $31,450 | 2 |
| Merck Sharp & Dohme LLC | $27,113 | 3 |
| Abbvie INC. | $20,347 | 2 |
| E.R. Squibb & Sons, L.L.C. | $14,616 | 2 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| DS8201-772 Daiichi Sankyo Inc. · NCT06819007 | $80,000 |
| CAMBRIA-2 A Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Camizestrant (AZD9833, a Next Generation, Oral Selective Est… AstraZeneca UK Limited | $48,965 |
| A22-301 PharmaEssentia USA Corporation | $36,918 |
| a phase III,two arm,parallel,randomized,multi center,open label,global study to determine the efficacy of volrustomig,plus chemotherapy versus pembro… AstraZeneca Pharmaceuticals LP | $34,172 |
| A Phase 3, Two-Stage, Randomized, Multicenter, Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) versus Daratumumab, Bort… Celgene Corporation | $31,450 |
| A Randomized Phase 3 Study Evaluating Cystectomy with Perioperative Pembrolizumab and Cystectomy with Perioperative Enfortumab Vedotin and Pembrolizu… Merck Sharp & Dohme LLC | $26,996 |
| Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Ovarian, Fallopian Tube, or Peritoneal Cancer (GLO… ABBVIE INC. · NCT05445778 | $20,347 |
| an observational,prospective,multicenter study of non small cell lung cancer patients in the US receiving standard of care and initiating an approved… AstraZeneca UK Limited | $15,250 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Greater Baltimore Medical Center
Is Greater Baltimore Medical Center a good hospital?
Greater Baltimore Medical Center has a CMS overall rating of 5 out of 5 stars. Of the 24 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 6 and worse on 1. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Greater Baltimore Medical Center?
77% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 775 completed HCAHPS surveys.
How long is the wait in the Greater Baltimore Medical Center emergency room?
Emergency patients spend a median of 3 h 48 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with high patient volume, like this one, the median is 3 h 22 min. 4% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Greater Baltimore Medical Center receive money from drug and device companies?
Drug and device makers reported $360,161 in payments to Greater Baltimore Medical Center for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.